COVID-19 Impact on Global Radiopharmaceuticals in Nuclear Medical, Market Insights and Forecast to 2026
Radiopharmaceuticals in Nuclear Medical market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Radiopharmaceuticals in Nuclear Medical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Radiopharmaceuticals in Nuclear Medical market is segmented into
The Radiopharmaceuticals in Nuclear Medical market is analysed and market size information is provided by regions (countries).
The key regions covered in the Radiopharmaceuticals in Nuclear Medical market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Radiopharmaceuticals in Nuclear Medical Market Share Analysis
Radiopharmaceuticals in Nuclear Medical market competitive landscape provides details and data information by manufacturers.
The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Radiopharmaceuticals in Nuclear Medical by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Radiopharmaceuticals in Nuclear Medical business, the date to enter into the Radiopharmaceuticals in Nuclear Medical market, Radiopharmaceuticals in Nuclear Medical product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Radiopharmaceuticals in Nuclear Medical market is segmented into
- Diagnostic Radiopharmaceuticals
- Therapy Radiopharmaceuticals
- Enriched Stable Isotopes
- Diagnostic Application
- Therapeutic Application
- Research
- Pharmaceutical
- Industrial
The Radiopharmaceuticals in Nuclear Medical market is analysed and market size information is provided by regions (countries).
The key regions covered in the Radiopharmaceuticals in Nuclear Medical market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Radiopharmaceuticals in Nuclear Medical Market Share Analysis
Radiopharmaceuticals in Nuclear Medical market competitive landscape provides details and data information by manufacturers.
The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Radiopharmaceuticals in Nuclear Medical by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Radiopharmaceuticals in Nuclear Medical business, the date to enter into the Radiopharmaceuticals in Nuclear Medical market, Radiopharmaceuticals in Nuclear Medical product introduction, recent developments, etc.
The major vendors covered:
- Bracco Imaging
- Cambridge Isotope Laboratories
- Cardinal Health
- Medtronic
- Eczacibasi-Monrol
- Fujifilm Holdings Corporation
- GE Healthcare (Subsidiary Of General Electric Company)
- IBA Group
- Lantheus Medical Imaging
- Nordion
- Ntp Radioisotopes
- Siemens Healthcare
- Taiyo Nippon Sanso Corporation
- Urenco Limited
1 STUDY COVERAGE
1.1 Radiopharmaceuticals in Nuclear Medical Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Radiopharmaceuticals in Nuclear Medical Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Radiopharmaceuticals in Nuclear Medical Market Size Growth Rate by Type
1.4.2 Diagnostic Radiopharmaceuticals
1.4.3 Therapy Radiopharmaceuticals
1.4.4 Enriched Stable Isotopes
1.5 Market by Application
1.5.1 Global Radiopharmaceuticals in Nuclear Medical Market Size Growth Rate by Application
1.5.2 Diagnostic Application
1.5.3 Therapeutic Application
1.5.4 Research
1.5.5 Pharmaceutical
1.5.6 Industrial
1.6 Coronavirus Disease 2019 (Covid-19): Radiopharmaceuticals in Nuclear Medical Industry Impact
1.6.1 How the Covid-19 is Affecting the Radiopharmaceuticals in Nuclear Medical Industry
1.6.1.1 Radiopharmaceuticals in Nuclear Medical Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Radiopharmaceuticals in Nuclear Medical Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Radiopharmaceuticals in Nuclear Medical Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Radiopharmaceuticals in Nuclear Medical Market Size Estimates and Forecasts
2.1.1 Global Radiopharmaceuticals in Nuclear Medical Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Radiopharmaceuticals in Nuclear Medical Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Radiopharmaceuticals in Nuclear Medical Production Estimates and Forecasts 2015-2026
2.2 Global Radiopharmaceuticals in Nuclear Medical Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Radiopharmaceuticals in Nuclear Medical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Radiopharmaceuticals in Nuclear Medical Manufacturers Geographical Distribution
2.4 Key Trends for Radiopharmaceuticals in Nuclear Medical Markets & Products
2.5 Primary Interviews with Key Radiopharmaceuticals in Nuclear Medical Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top Radiopharmaceuticals in Nuclear Medical Manufacturers by Production Capacity
3.1.1 Global Top Radiopharmaceuticals in Nuclear Medical Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Radiopharmaceuticals in Nuclear Medical Manufacturers by Production (2015-2020)
3.1.3 Global Top Radiopharmaceuticals in Nuclear Medical Manufacturers Market Share by Production
3.2 Global Top Radiopharmaceuticals in Nuclear Medical Manufacturers by Revenue
3.2.1 Global Top Radiopharmaceuticals in Nuclear Medical Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Radiopharmaceuticals in Nuclear Medical Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Radiopharmaceuticals in Nuclear Medical Revenue in 2019
3.3 Global Radiopharmaceuticals in Nuclear Medical Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 RADIOPHARMACEUTICALS IN NUCLEAR MEDICAL PRODUCTION BY REGIONS
4.1 Global Radiopharmaceuticals in Nuclear Medical Historic Market Facts & Figures by Regions
4.1.1 Global Top Radiopharmaceuticals in Nuclear Medical Regions by Production (2015-2020)
4.1.2 Global Top Radiopharmaceuticals in Nuclear Medical Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Radiopharmaceuticals in Nuclear Medical Production (2015-2020)
4.2.2 North America Radiopharmaceuticals in Nuclear Medical Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Radiopharmaceuticals in Nuclear Medical Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Radiopharmaceuticals in Nuclear Medical Production (2015-2020)
4.3.2 Europe Radiopharmaceuticals in Nuclear Medical Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Radiopharmaceuticals in Nuclear Medical Import & Export (2015-2020)
4.4 China
4.4.1 China Radiopharmaceuticals in Nuclear Medical Production (2015-2020)
4.4.2 China Radiopharmaceuticals in Nuclear Medical Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Radiopharmaceuticals in Nuclear Medical Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Radiopharmaceuticals in Nuclear Medical Production (2015-2020)
4.5.2 Japan Radiopharmaceuticals in Nuclear Medical Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Radiopharmaceuticals in Nuclear Medical Import & Export (2015-2020)
5 RADIOPHARMACEUTICALS IN NUCLEAR MEDICAL CONSUMPTION BY REGION
5.1 Global Top Radiopharmaceuticals in Nuclear Medical Regions by Consumption
5.1.1 Global Top Radiopharmaceuticals in Nuclear Medical Regions by Consumption (2015-2020)
5.1.2 Global Top Radiopharmaceuticals in Nuclear Medical Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Radiopharmaceuticals in Nuclear Medical Consumption by Application
5.2.2 North America Radiopharmaceuticals in Nuclear Medical Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Radiopharmaceuticals in Nuclear Medical Consumption by Application
5.3.2 Europe Radiopharmaceuticals in Nuclear Medical Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Radiopharmaceuticals in Nuclear Medical Consumption by Application
5.4.2 Asia Pacific Radiopharmaceuticals in Nuclear Medical Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Radiopharmaceuticals in Nuclear Medical Consumption by Application
5.5.2 Central & South America Radiopharmaceuticals in Nuclear Medical Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Consumption by Application
5.6.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global Radiopharmaceuticals in Nuclear Medical Market Size by Type (2015-2020)
6.1.1 Global Radiopharmaceuticals in Nuclear Medical Production by Type (2015-2020)
6.1.2 Global Radiopharmaceuticals in Nuclear Medical Revenue by Type (2015-2020)
6.1.3 Radiopharmaceuticals in Nuclear Medical Price by Type (2015-2020)
6.2 Global Radiopharmaceuticals in Nuclear Medical Market Forecast by Type (2021-2026)
6.2.1 Global Radiopharmaceuticals in Nuclear Medical Production Forecast by Type (2021-2026)
6.2.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Type (2021-2026)
6.2.3 Global Radiopharmaceuticals in Nuclear Medical Price Forecast by Type (2021-2026)
6.3 Global Radiopharmaceuticals in Nuclear Medical Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global Radiopharmaceuticals in Nuclear Medical Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 Bracco Imaging
8.1.1 Bracco Imaging Corporation Information
8.1.2 Bracco Imaging Overview and Its Total Revenue
8.1.3 Bracco Imaging Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Bracco Imaging Product Description
8.1.5 Bracco Imaging Recent Development
8.2 Cambridge Isotope Laboratories
8.2.1 Cambridge Isotope Laboratories Corporation Information
8.2.2 Cambridge Isotope Laboratories Overview and Its Total Revenue
8.2.3 Cambridge Isotope Laboratories Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Cambridge Isotope Laboratories Product Description
8.2.5 Cambridge Isotope Laboratories Recent Development
8.3 Cardinal Health
8.3.1 Cardinal Health Corporation Information
8.3.2 Cardinal Health Overview and Its Total Revenue
8.3.3 Cardinal Health Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Cardinal Health Product Description
8.3.5 Cardinal Health Recent Development
8.4 Medtronic
8.4.1 Medtronic Corporation Information
8.4.2 Medtronic Overview and Its Total Revenue
8.4.3 Medtronic Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Medtronic Product Description
8.4.5 Medtronic Recent Development
8.5 Eczacibasi-Monrol
8.5.1 Eczacibasi-Monrol Corporation Information
8.5.2 Eczacibasi-Monrol Overview and Its Total Revenue
8.5.3 Eczacibasi-Monrol Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Eczacibasi-Monrol Product Description
8.5.5 Eczacibasi-Monrol Recent Development
8.6 Fujifilm Holdings Corporation
8.6.1 Fujifilm Holdings Corporation Corporation Information
8.6.2 Fujifilm Holdings Corporation Overview and Its Total Revenue
8.6.3 Fujifilm Holdings Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Fujifilm Holdings Corporation Product Description
8.6.5 Fujifilm Holdings Corporation Recent Development
8.7 GE Healthcare (Subsidiary Of General Electric Company)
8.7.1 GE Healthcare (Subsidiary Of General Electric Company) Corporation Information
8.7.2 GE Healthcare (Subsidiary Of General Electric Company) Overview and Its Total Revenue
8.7.3 GE Healthcare (Subsidiary Of General Electric Company) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 GE Healthcare (Subsidiary Of General Electric Company) Product Description
8.7.5 GE Healthcare (Subsidiary Of General Electric Company) Recent Development
8.8 IBA Group
8.8.1 IBA Group Corporation Information
8.8.2 IBA Group Overview and Its Total Revenue
8.8.3 IBA Group Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 IBA Group Product Description
8.8.5 IBA Group Recent Development
8.9 Lantheus Medical Imaging
8.9.1 Lantheus Medical Imaging Corporation Information
8.9.2 Lantheus Medical Imaging Overview and Its Total Revenue
8.9.3 Lantheus Medical Imaging Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Lantheus Medical Imaging Product Description
8.9.5 Lantheus Medical Imaging Recent Development
8.10 Nordion
8.10.1 Nordion Corporation Information
8.10.2 Nordion Overview and Its Total Revenue
8.10.3 Nordion Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Nordion Product Description
8.10.5 Nordion Recent Development
8.11 Ntp Radioisotopes
8.11.1 Ntp Radioisotopes Corporation Information
8.11.2 Ntp Radioisotopes Overview and Its Total Revenue
8.11.3 Ntp Radioisotopes Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 Ntp Radioisotopes Product Description
8.11.5 Ntp Radioisotopes Recent Development
8.12 Siemens Healthcare
8.12.1 Siemens Healthcare Corporation Information
8.12.2 Siemens Healthcare Overview and Its Total Revenue
8.12.3 Siemens Healthcare Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.12.4 Siemens Healthcare Product Description
8.12.5 Siemens Healthcare Recent Development
8.13 Taiyo Nippon Sanso Corporation
8.13.1 Taiyo Nippon Sanso Corporation Corporation Information
8.13.2 Taiyo Nippon Sanso Corporation Overview and Its Total Revenue
8.13.3 Taiyo Nippon Sanso Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.13.4 Taiyo Nippon Sanso Corporation Product Description
8.13.5 Taiyo Nippon Sanso Corporation Recent Development
8.14 Urenco Limited
8.14.1 Urenco Limited Corporation Information
8.14.2 Urenco Limited Overview and Its Total Revenue
8.14.3 Urenco Limited Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.14.4 Urenco Limited Product Description
8.14.5 Urenco Limited Recent Development
8.15 Rotem Industries
8.15.1 Rotem Industries Corporation Information
8.15.2 Rotem Industries Overview and Its Total Revenue
8.15.3 Rotem Industries Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.15.4 Rotem Industries Product Description
8.15.5 Rotem Industries Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top Radiopharmaceuticals in Nuclear Medical Regions Forecast by Revenue (2021-2026)
9.2 Global Top Radiopharmaceuticals in Nuclear Medical Regions Forecast by Production (2021-2026)
9.3 Key Radiopharmaceuticals in Nuclear Medical Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 RADIOPHARMACEUTICALS IN NUCLEAR MEDICAL CONSUMPTION FORECAST BY REGION
10.1 Global Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Region (2021-2026)
10.2 North America Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Region (2021-2026)
10.3 Europe Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Region (2021-2026)
10.5 Latin America Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Radiopharmaceuticals in Nuclear Medical Sales Channels
11.2.2 Radiopharmaceuticals in Nuclear Medical Distributors
11.3 Radiopharmaceuticals in Nuclear Medical Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICAL STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
1.1 Radiopharmaceuticals in Nuclear Medical Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Radiopharmaceuticals in Nuclear Medical Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Radiopharmaceuticals in Nuclear Medical Market Size Growth Rate by Type
1.4.2 Diagnostic Radiopharmaceuticals
1.4.3 Therapy Radiopharmaceuticals
1.4.4 Enriched Stable Isotopes
1.5 Market by Application
1.5.1 Global Radiopharmaceuticals in Nuclear Medical Market Size Growth Rate by Application
1.5.2 Diagnostic Application
1.5.3 Therapeutic Application
1.5.4 Research
1.5.5 Pharmaceutical
1.5.6 Industrial
1.6 Coronavirus Disease 2019 (Covid-19): Radiopharmaceuticals in Nuclear Medical Industry Impact
1.6.1 How the Covid-19 is Affecting the Radiopharmaceuticals in Nuclear Medical Industry
1.6.1.1 Radiopharmaceuticals in Nuclear Medical Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Radiopharmaceuticals in Nuclear Medical Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Radiopharmaceuticals in Nuclear Medical Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Radiopharmaceuticals in Nuclear Medical Market Size Estimates and Forecasts
2.1.1 Global Radiopharmaceuticals in Nuclear Medical Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Radiopharmaceuticals in Nuclear Medical Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Radiopharmaceuticals in Nuclear Medical Production Estimates and Forecasts 2015-2026
2.2 Global Radiopharmaceuticals in Nuclear Medical Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Radiopharmaceuticals in Nuclear Medical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Radiopharmaceuticals in Nuclear Medical Manufacturers Geographical Distribution
2.4 Key Trends for Radiopharmaceuticals in Nuclear Medical Markets & Products
2.5 Primary Interviews with Key Radiopharmaceuticals in Nuclear Medical Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top Radiopharmaceuticals in Nuclear Medical Manufacturers by Production Capacity
3.1.1 Global Top Radiopharmaceuticals in Nuclear Medical Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Radiopharmaceuticals in Nuclear Medical Manufacturers by Production (2015-2020)
3.1.3 Global Top Radiopharmaceuticals in Nuclear Medical Manufacturers Market Share by Production
3.2 Global Top Radiopharmaceuticals in Nuclear Medical Manufacturers by Revenue
3.2.1 Global Top Radiopharmaceuticals in Nuclear Medical Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Radiopharmaceuticals in Nuclear Medical Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Radiopharmaceuticals in Nuclear Medical Revenue in 2019
3.3 Global Radiopharmaceuticals in Nuclear Medical Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 RADIOPHARMACEUTICALS IN NUCLEAR MEDICAL PRODUCTION BY REGIONS
4.1 Global Radiopharmaceuticals in Nuclear Medical Historic Market Facts & Figures by Regions
4.1.1 Global Top Radiopharmaceuticals in Nuclear Medical Regions by Production (2015-2020)
4.1.2 Global Top Radiopharmaceuticals in Nuclear Medical Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Radiopharmaceuticals in Nuclear Medical Production (2015-2020)
4.2.2 North America Radiopharmaceuticals in Nuclear Medical Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Radiopharmaceuticals in Nuclear Medical Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Radiopharmaceuticals in Nuclear Medical Production (2015-2020)
4.3.2 Europe Radiopharmaceuticals in Nuclear Medical Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Radiopharmaceuticals in Nuclear Medical Import & Export (2015-2020)
4.4 China
4.4.1 China Radiopharmaceuticals in Nuclear Medical Production (2015-2020)
4.4.2 China Radiopharmaceuticals in Nuclear Medical Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Radiopharmaceuticals in Nuclear Medical Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Radiopharmaceuticals in Nuclear Medical Production (2015-2020)
4.5.2 Japan Radiopharmaceuticals in Nuclear Medical Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Radiopharmaceuticals in Nuclear Medical Import & Export (2015-2020)
5 RADIOPHARMACEUTICALS IN NUCLEAR MEDICAL CONSUMPTION BY REGION
5.1 Global Top Radiopharmaceuticals in Nuclear Medical Regions by Consumption
5.1.1 Global Top Radiopharmaceuticals in Nuclear Medical Regions by Consumption (2015-2020)
5.1.2 Global Top Radiopharmaceuticals in Nuclear Medical Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Radiopharmaceuticals in Nuclear Medical Consumption by Application
5.2.2 North America Radiopharmaceuticals in Nuclear Medical Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Radiopharmaceuticals in Nuclear Medical Consumption by Application
5.3.2 Europe Radiopharmaceuticals in Nuclear Medical Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Radiopharmaceuticals in Nuclear Medical Consumption by Application
5.4.2 Asia Pacific Radiopharmaceuticals in Nuclear Medical Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Radiopharmaceuticals in Nuclear Medical Consumption by Application
5.5.2 Central & South America Radiopharmaceuticals in Nuclear Medical Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Consumption by Application
5.6.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global Radiopharmaceuticals in Nuclear Medical Market Size by Type (2015-2020)
6.1.1 Global Radiopharmaceuticals in Nuclear Medical Production by Type (2015-2020)
6.1.2 Global Radiopharmaceuticals in Nuclear Medical Revenue by Type (2015-2020)
6.1.3 Radiopharmaceuticals in Nuclear Medical Price by Type (2015-2020)
6.2 Global Radiopharmaceuticals in Nuclear Medical Market Forecast by Type (2021-2026)
6.2.1 Global Radiopharmaceuticals in Nuclear Medical Production Forecast by Type (2021-2026)
6.2.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Type (2021-2026)
6.2.3 Global Radiopharmaceuticals in Nuclear Medical Price Forecast by Type (2021-2026)
6.3 Global Radiopharmaceuticals in Nuclear Medical Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global Radiopharmaceuticals in Nuclear Medical Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 Bracco Imaging
8.1.1 Bracco Imaging Corporation Information
8.1.2 Bracco Imaging Overview and Its Total Revenue
8.1.3 Bracco Imaging Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Bracco Imaging Product Description
8.1.5 Bracco Imaging Recent Development
8.2 Cambridge Isotope Laboratories
8.2.1 Cambridge Isotope Laboratories Corporation Information
8.2.2 Cambridge Isotope Laboratories Overview and Its Total Revenue
8.2.3 Cambridge Isotope Laboratories Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Cambridge Isotope Laboratories Product Description
8.2.5 Cambridge Isotope Laboratories Recent Development
8.3 Cardinal Health
8.3.1 Cardinal Health Corporation Information
8.3.2 Cardinal Health Overview and Its Total Revenue
8.3.3 Cardinal Health Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Cardinal Health Product Description
8.3.5 Cardinal Health Recent Development
8.4 Medtronic
8.4.1 Medtronic Corporation Information
8.4.2 Medtronic Overview and Its Total Revenue
8.4.3 Medtronic Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Medtronic Product Description
8.4.5 Medtronic Recent Development
8.5 Eczacibasi-Monrol
8.5.1 Eczacibasi-Monrol Corporation Information
8.5.2 Eczacibasi-Monrol Overview and Its Total Revenue
8.5.3 Eczacibasi-Monrol Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Eczacibasi-Monrol Product Description
8.5.5 Eczacibasi-Monrol Recent Development
8.6 Fujifilm Holdings Corporation
8.6.1 Fujifilm Holdings Corporation Corporation Information
8.6.2 Fujifilm Holdings Corporation Overview and Its Total Revenue
8.6.3 Fujifilm Holdings Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Fujifilm Holdings Corporation Product Description
8.6.5 Fujifilm Holdings Corporation Recent Development
8.7 GE Healthcare (Subsidiary Of General Electric Company)
8.7.1 GE Healthcare (Subsidiary Of General Electric Company) Corporation Information
8.7.2 GE Healthcare (Subsidiary Of General Electric Company) Overview and Its Total Revenue
8.7.3 GE Healthcare (Subsidiary Of General Electric Company) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 GE Healthcare (Subsidiary Of General Electric Company) Product Description
8.7.5 GE Healthcare (Subsidiary Of General Electric Company) Recent Development
8.8 IBA Group
8.8.1 IBA Group Corporation Information
8.8.2 IBA Group Overview and Its Total Revenue
8.8.3 IBA Group Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 IBA Group Product Description
8.8.5 IBA Group Recent Development
8.9 Lantheus Medical Imaging
8.9.1 Lantheus Medical Imaging Corporation Information
8.9.2 Lantheus Medical Imaging Overview and Its Total Revenue
8.9.3 Lantheus Medical Imaging Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Lantheus Medical Imaging Product Description
8.9.5 Lantheus Medical Imaging Recent Development
8.10 Nordion
8.10.1 Nordion Corporation Information
8.10.2 Nordion Overview and Its Total Revenue
8.10.3 Nordion Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Nordion Product Description
8.10.5 Nordion Recent Development
8.11 Ntp Radioisotopes
8.11.1 Ntp Radioisotopes Corporation Information
8.11.2 Ntp Radioisotopes Overview and Its Total Revenue
8.11.3 Ntp Radioisotopes Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 Ntp Radioisotopes Product Description
8.11.5 Ntp Radioisotopes Recent Development
8.12 Siemens Healthcare
8.12.1 Siemens Healthcare Corporation Information
8.12.2 Siemens Healthcare Overview and Its Total Revenue
8.12.3 Siemens Healthcare Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.12.4 Siemens Healthcare Product Description
8.12.5 Siemens Healthcare Recent Development
8.13 Taiyo Nippon Sanso Corporation
8.13.1 Taiyo Nippon Sanso Corporation Corporation Information
8.13.2 Taiyo Nippon Sanso Corporation Overview and Its Total Revenue
8.13.3 Taiyo Nippon Sanso Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.13.4 Taiyo Nippon Sanso Corporation Product Description
8.13.5 Taiyo Nippon Sanso Corporation Recent Development
8.14 Urenco Limited
8.14.1 Urenco Limited Corporation Information
8.14.2 Urenco Limited Overview and Its Total Revenue
8.14.3 Urenco Limited Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.14.4 Urenco Limited Product Description
8.14.5 Urenco Limited Recent Development
8.15 Rotem Industries
8.15.1 Rotem Industries Corporation Information
8.15.2 Rotem Industries Overview and Its Total Revenue
8.15.3 Rotem Industries Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.15.4 Rotem Industries Product Description
8.15.5 Rotem Industries Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top Radiopharmaceuticals in Nuclear Medical Regions Forecast by Revenue (2021-2026)
9.2 Global Top Radiopharmaceuticals in Nuclear Medical Regions Forecast by Production (2021-2026)
9.3 Key Radiopharmaceuticals in Nuclear Medical Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 RADIOPHARMACEUTICALS IN NUCLEAR MEDICAL CONSUMPTION FORECAST BY REGION
10.1 Global Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Region (2021-2026)
10.2 North America Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Region (2021-2026)
10.3 Europe Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Region (2021-2026)
10.5 Latin America Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Radiopharmaceuticals in Nuclear Medical Sales Channels
11.2.2 Radiopharmaceuticals in Nuclear Medical Distributors
11.3 Radiopharmaceuticals in Nuclear Medical Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICAL STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
LIST OF TABLES
Table 1. Radiopharmaceuticals in Nuclear Medical Key Market Segments in This Study
Table 2. Ranking of Global Top Radiopharmaceuticals in Nuclear Medical Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Radiopharmaceuticals in Nuclear Medical Market Size Growth Rate by Type 2020-2026 (K MT) (Million US$)
Table 4. Major Manufacturers of Diagnostic Radiopharmaceuticals
Table 5. Major Manufacturers of Therapy Radiopharmaceuticals
Table 6. Major Manufacturers of Enriched Stable Isotopes
Table 7. COVID-19 Impact Global Market: (Four Radiopharmaceuticals in Nuclear Medical Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Radiopharmaceuticals in Nuclear Medical Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Radiopharmaceuticals in Nuclear Medical Players to Combat Covid-19 Impact
Table 12. Global Radiopharmaceuticals in Nuclear Medical Market Size Growth Rate by Application 2020-2026 (K MT)
Table 13. Global Radiopharmaceuticals in Nuclear Medical Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Radiopharmaceuticals in Nuclear Medical by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radiopharmaceuticals in Nuclear Medical as of 2019)
Table 16. Radiopharmaceuticals in Nuclear Medical Manufacturing Base Distribution and Headquarters
Table 17. Manufacturers Radiopharmaceuticals in Nuclear Medical Product Offered
Table 18. Date of Manufacturers Enter into Radiopharmaceuticals in Nuclear Medical Market
Table 19. Key Trends for Radiopharmaceuticals in Nuclear Medical Markets & Products
Table 20. Main Points Interviewed from Key Radiopharmaceuticals in Nuclear Medical Players
Table 21. Global Radiopharmaceuticals in Nuclear Medical Production Capacity by Manufacturers (2015-2020) (K MT)
Table 22. Global Radiopharmaceuticals in Nuclear Medical Production Share by Manufacturers (2015-2020)
Table 23. Radiopharmaceuticals in Nuclear Medical Revenue by Manufacturers (2015-2020) (Million US$)
Table 24. Radiopharmaceuticals in Nuclear Medical Revenue Share by Manufacturers (2015-2020)
Table 25. Radiopharmaceuticals in Nuclear Medical Price by Manufacturers 2015-2020 (USD/MT)
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Radiopharmaceuticals in Nuclear Medical Production by Regions (2015-2020) (K MT)
Table 28. Global Radiopharmaceuticals in Nuclear Medical Production Market Share by Regions (2015-2020)
Table 29. Global Radiopharmaceuticals in Nuclear Medical Revenue by Regions (2015-2020) (US$ Million)
Table 30. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Regions (2015-2020)
Table 31. Key Radiopharmaceuticals in Nuclear Medical Players in North America
Table 32. Import & Export of Radiopharmaceuticals in Nuclear Medical in North America (K MT)
Table 33. Key Radiopharmaceuticals in Nuclear Medical Players in Europe
Table 34. Import & Export of Radiopharmaceuticals in Nuclear Medical in Europe (K MT)
Table 35. Key Radiopharmaceuticals in Nuclear Medical Players in China
Table 36. Import & Export of Radiopharmaceuticals in Nuclear Medical in China (K MT)
Table 37. Key Radiopharmaceuticals in Nuclear Medical Players in Japan
Table 38. Import & Export of Radiopharmaceuticals in Nuclear Medical in Japan (K MT)
Table 39. Global Radiopharmaceuticals in Nuclear Medical Consumption by Regions (2015-2020) (K MT)
Table 40. Global Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Regions (2015-2020)
Table 41. North America Radiopharmaceuticals in Nuclear Medical Consumption by Application (2015-2020) (K MT)
Table 42. North America Radiopharmaceuticals in Nuclear Medical Consumption by Countries (2015-2020) (K MT)
Table 43. Europe Radiopharmaceuticals in Nuclear Medical Consumption by Application (2015-2020) (K MT)
Table 44. Europe Radiopharmaceuticals in Nuclear Medical Consumption by Countries (2015-2020) (K MT)
Table 45. Asia Pacific Radiopharmaceuticals in Nuclear Medical Consumption by Application (2015-2020) (K MT)
Table 46. Asia Pacific Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Application (2015-2020) (K MT)
Table 47. Asia Pacific Radiopharmaceuticals in Nuclear Medical Consumption by Regions (2015-2020) (K MT)
Table 48. Latin America Radiopharmaceuticals in Nuclear Medical Consumption by Application (2015-2020) (K MT)
Table 49. Latin America Radiopharmaceuticals in Nuclear Medical Consumption by Countries (2015-2020) (K MT)
Table 50. Middle East and Africa Radiopharmaceuticals in Nuclear Medical Consumption by Application (2015-2020) (K MT)
Table 51. Middle East and Africa Radiopharmaceuticals in Nuclear Medical Consumption by Countries (2015-2020) (K MT)
Table 52. Global Radiopharmaceuticals in Nuclear Medical Production by Type (2015-2020) (K MT)
Table 53. Global Radiopharmaceuticals in Nuclear Medical Production Share by Type (2015-2020)
Table 54. Global Radiopharmaceuticals in Nuclear Medical Revenue by Type (2015-2020) (Million US$)
Table 55. Global Radiopharmaceuticals in Nuclear Medical Revenue Share by Type (2015-2020)
Table 56. Radiopharmaceuticals in Nuclear Medical Price by Type 2015-2020 (USD/MT)
Table 57. Global Radiopharmaceuticals in Nuclear Medical Consumption by Application (2015-2020) (K MT)
Table 58. Global Radiopharmaceuticals in Nuclear Medical Consumption by Application (2015-2020) (K MT)
Table 59. Global Radiopharmaceuticals in Nuclear Medical Consumption Share by Application (2015-2020)
Table 60. Bracco Imaging Corporation Information
Table 61. Bracco Imaging Description and Major Businesses
Table 62. Bracco Imaging Radiopharmaceuticals in Nuclear Medical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 63. Bracco Imaging Product
Table 64. Bracco Imaging Recent Development
Table 65. Cambridge Isotope Laboratories Corporation Information
Table 66. Cambridge Isotope Laboratories Description and Major Businesses
Table 67. Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 68. Cambridge Isotope Laboratories Product
Table 69. Cambridge Isotope Laboratories Recent Development
Table 70. Cardinal Health Corporation Information
Table 71. Cardinal Health Description and Major Businesses
Table 72. Cardinal Health Radiopharmaceuticals in Nuclear Medical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 73. Cardinal Health Product
Table 74. Cardinal Health Recent Development
Table 75. Medtronic Corporation Information
Table 76. Medtronic Description and Major Businesses
Table 77. Medtronic Radiopharmaceuticals in Nuclear Medical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Medtronic Product
Table 79. Medtronic Recent Development
Table 80. Eczacibasi-Monrol Corporation Information
Table 81. Eczacibasi-Monrol Description and Major Businesses
Table 82. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Eczacibasi-Monrol Product
Table 84. Eczacibasi-Monrol Recent Development
Table 85. Fujifilm Holdings Corporation Corporation Information
Table 86. Fujifilm Holdings Corporation Description and Major Businesses
Table 87. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Fujifilm Holdings Corporation Product
Table 89. Fujifilm Holdings Corporation Recent Development
Table 90. GE Healthcare (Subsidiary Of General Electric Company) Corporation Information
Table 91. GE Healthcare (Subsidiary Of General Electric Company) Description and Major Businesses
Table 92. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. GE Healthcare (Subsidiary Of General Electric Company) Product
Table 94. GE Healthcare (Subsidiary Of General Electric Company) Recent Development
Table 95. IBA Group Corporation Information
Table 96. IBA Group Description and Major Businesses
Table 97. IBA Group Radiopharmaceuticals in Nuclear Medical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. IBA Group Product
Table 99. IBA Group Recent Development
Table 100. Lantheus Medical Imaging Corporation Information
Table 101. Lantheus Medical Imaging Description and Major Businesses
Table 102. Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Lantheus Medical Imaging Product
Table 104. Lantheus Medical Imaging Recent Development
Table 105. Nordion Corporation Information
Table 106. Nordion Description and Major Businesses
Table 107. Nordion Radiopharmaceuticals in Nuclear Medical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Nordion Product
Table 109. Nordion Recent Development
Table 110. Ntp Radioisotopes Corporation Information
Table 111. Ntp Radioisotopes Description and Major Businesses
Table 112. Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Ntp Radioisotopes Product
Table 114. Ntp Radioisotopes Recent Development
Table 115. Siemens Healthcare Corporation Information
Table 116. Siemens Healthcare Description and Major Businesses
Table 117. Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. Siemens Healthcare Product
Table 119. Siemens Healthcare Recent Development
Table 120. Taiyo Nippon Sanso Corporation Corporation Information
Table 121. Taiyo Nippon Sanso Corporation Description and Major Businesses
Table 122. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Taiyo Nippon Sanso Corporation Product
Table 124. Taiyo Nippon Sanso Corporation Recent Development
Table 125. Urenco Limited Corporation Information
Table 126. Urenco Limited Description and Major Businesses
Table 127. Urenco Limited Radiopharmaceuticals in Nuclear Medical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Urenco Limited Product
Table 129. Urenco Limited Recent Development
Table 130. Rotem Industries Corporation Information
Table 131. Rotem Industries Description and Major Businesses
Table 132. Rotem Industries Radiopharmaceuticals in Nuclear Medical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Rotem Industries Product
Table 134. Rotem Industries Recent Development
Table 135. Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Region (2021-2026) (Million US$)
Table 136. Global Radiopharmaceuticals in Nuclear Medical Production Forecast by Regions (2021-2026) (K MT)
Table 137. Global Radiopharmaceuticals in Nuclear Medical Production Forecast by Type (2021-2026) (K MT)
Table 138. Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Type (2021-2026) (Million US$)
Table 139. North America Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Regions (2021-2026) (K MT)
Table 140. Europe Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Regions (2021-2026) (K MT)
Table 141. Asia Pacific Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Regions (2021-2026) (K MT)
Table 142. Latin America Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Regions (2021-2026) (K MT)
Table 143. Middle East and Africa Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Regions (2021-2026) (K MT)
Table 144. Radiopharmaceuticals in Nuclear Medical Distributors List
Table 145. Radiopharmaceuticals in Nuclear Medical Customers List
Table 146. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 147. Key Challenges
Table 148. Market Risks
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
Table 1. Radiopharmaceuticals in Nuclear Medical Key Market Segments in This Study
Table 2. Ranking of Global Top Radiopharmaceuticals in Nuclear Medical Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Radiopharmaceuticals in Nuclear Medical Market Size Growth Rate by Type 2020-2026 (K MT) (Million US$)
Table 4. Major Manufacturers of Diagnostic Radiopharmaceuticals
Table 5. Major Manufacturers of Therapy Radiopharmaceuticals
Table 6. Major Manufacturers of Enriched Stable Isotopes
Table 7. COVID-19 Impact Global Market: (Four Radiopharmaceuticals in Nuclear Medical Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Radiopharmaceuticals in Nuclear Medical Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Radiopharmaceuticals in Nuclear Medical Players to Combat Covid-19 Impact
Table 12. Global Radiopharmaceuticals in Nuclear Medical Market Size Growth Rate by Application 2020-2026 (K MT)
Table 13. Global Radiopharmaceuticals in Nuclear Medical Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Radiopharmaceuticals in Nuclear Medical by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radiopharmaceuticals in Nuclear Medical as of 2019)
Table 16. Radiopharmaceuticals in Nuclear Medical Manufacturing Base Distribution and Headquarters
Table 17. Manufacturers Radiopharmaceuticals in Nuclear Medical Product Offered
Table 18. Date of Manufacturers Enter into Radiopharmaceuticals in Nuclear Medical Market
Table 19. Key Trends for Radiopharmaceuticals in Nuclear Medical Markets & Products
Table 20. Main Points Interviewed from Key Radiopharmaceuticals in Nuclear Medical Players
Table 21. Global Radiopharmaceuticals in Nuclear Medical Production Capacity by Manufacturers (2015-2020) (K MT)
Table 22. Global Radiopharmaceuticals in Nuclear Medical Production Share by Manufacturers (2015-2020)
Table 23. Radiopharmaceuticals in Nuclear Medical Revenue by Manufacturers (2015-2020) (Million US$)
Table 24. Radiopharmaceuticals in Nuclear Medical Revenue Share by Manufacturers (2015-2020)
Table 25. Radiopharmaceuticals in Nuclear Medical Price by Manufacturers 2015-2020 (USD/MT)
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Radiopharmaceuticals in Nuclear Medical Production by Regions (2015-2020) (K MT)
Table 28. Global Radiopharmaceuticals in Nuclear Medical Production Market Share by Regions (2015-2020)
Table 29. Global Radiopharmaceuticals in Nuclear Medical Revenue by Regions (2015-2020) (US$ Million)
Table 30. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Regions (2015-2020)
Table 31. Key Radiopharmaceuticals in Nuclear Medical Players in North America
Table 32. Import & Export of Radiopharmaceuticals in Nuclear Medical in North America (K MT)
Table 33. Key Radiopharmaceuticals in Nuclear Medical Players in Europe
Table 34. Import & Export of Radiopharmaceuticals in Nuclear Medical in Europe (K MT)
Table 35. Key Radiopharmaceuticals in Nuclear Medical Players in China
Table 36. Import & Export of Radiopharmaceuticals in Nuclear Medical in China (K MT)
Table 37. Key Radiopharmaceuticals in Nuclear Medical Players in Japan
Table 38. Import & Export of Radiopharmaceuticals in Nuclear Medical in Japan (K MT)
Table 39. Global Radiopharmaceuticals in Nuclear Medical Consumption by Regions (2015-2020) (K MT)
Table 40. Global Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Regions (2015-2020)
Table 41. North America Radiopharmaceuticals in Nuclear Medical Consumption by Application (2015-2020) (K MT)
Table 42. North America Radiopharmaceuticals in Nuclear Medical Consumption by Countries (2015-2020) (K MT)
Table 43. Europe Radiopharmaceuticals in Nuclear Medical Consumption by Application (2015-2020) (K MT)
Table 44. Europe Radiopharmaceuticals in Nuclear Medical Consumption by Countries (2015-2020) (K MT)
Table 45. Asia Pacific Radiopharmaceuticals in Nuclear Medical Consumption by Application (2015-2020) (K MT)
Table 46. Asia Pacific Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Application (2015-2020) (K MT)
Table 47. Asia Pacific Radiopharmaceuticals in Nuclear Medical Consumption by Regions (2015-2020) (K MT)
Table 48. Latin America Radiopharmaceuticals in Nuclear Medical Consumption by Application (2015-2020) (K MT)
Table 49. Latin America Radiopharmaceuticals in Nuclear Medical Consumption by Countries (2015-2020) (K MT)
Table 50. Middle East and Africa Radiopharmaceuticals in Nuclear Medical Consumption by Application (2015-2020) (K MT)
Table 51. Middle East and Africa Radiopharmaceuticals in Nuclear Medical Consumption by Countries (2015-2020) (K MT)
Table 52. Global Radiopharmaceuticals in Nuclear Medical Production by Type (2015-2020) (K MT)
Table 53. Global Radiopharmaceuticals in Nuclear Medical Production Share by Type (2015-2020)
Table 54. Global Radiopharmaceuticals in Nuclear Medical Revenue by Type (2015-2020) (Million US$)
Table 55. Global Radiopharmaceuticals in Nuclear Medical Revenue Share by Type (2015-2020)
Table 56. Radiopharmaceuticals in Nuclear Medical Price by Type 2015-2020 (USD/MT)
Table 57. Global Radiopharmaceuticals in Nuclear Medical Consumption by Application (2015-2020) (K MT)
Table 58. Global Radiopharmaceuticals in Nuclear Medical Consumption by Application (2015-2020) (K MT)
Table 59. Global Radiopharmaceuticals in Nuclear Medical Consumption Share by Application (2015-2020)
Table 60. Bracco Imaging Corporation Information
Table 61. Bracco Imaging Description and Major Businesses
Table 62. Bracco Imaging Radiopharmaceuticals in Nuclear Medical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 63. Bracco Imaging Product
Table 64. Bracco Imaging Recent Development
Table 65. Cambridge Isotope Laboratories Corporation Information
Table 66. Cambridge Isotope Laboratories Description and Major Businesses
Table 67. Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 68. Cambridge Isotope Laboratories Product
Table 69. Cambridge Isotope Laboratories Recent Development
Table 70. Cardinal Health Corporation Information
Table 71. Cardinal Health Description and Major Businesses
Table 72. Cardinal Health Radiopharmaceuticals in Nuclear Medical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 73. Cardinal Health Product
Table 74. Cardinal Health Recent Development
Table 75. Medtronic Corporation Information
Table 76. Medtronic Description and Major Businesses
Table 77. Medtronic Radiopharmaceuticals in Nuclear Medical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Medtronic Product
Table 79. Medtronic Recent Development
Table 80. Eczacibasi-Monrol Corporation Information
Table 81. Eczacibasi-Monrol Description and Major Businesses
Table 82. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Eczacibasi-Monrol Product
Table 84. Eczacibasi-Monrol Recent Development
Table 85. Fujifilm Holdings Corporation Corporation Information
Table 86. Fujifilm Holdings Corporation Description and Major Businesses
Table 87. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Fujifilm Holdings Corporation Product
Table 89. Fujifilm Holdings Corporation Recent Development
Table 90. GE Healthcare (Subsidiary Of General Electric Company) Corporation Information
Table 91. GE Healthcare (Subsidiary Of General Electric Company) Description and Major Businesses
Table 92. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. GE Healthcare (Subsidiary Of General Electric Company) Product
Table 94. GE Healthcare (Subsidiary Of General Electric Company) Recent Development
Table 95. IBA Group Corporation Information
Table 96. IBA Group Description and Major Businesses
Table 97. IBA Group Radiopharmaceuticals in Nuclear Medical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. IBA Group Product
Table 99. IBA Group Recent Development
Table 100. Lantheus Medical Imaging Corporation Information
Table 101. Lantheus Medical Imaging Description and Major Businesses
Table 102. Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Lantheus Medical Imaging Product
Table 104. Lantheus Medical Imaging Recent Development
Table 105. Nordion Corporation Information
Table 106. Nordion Description and Major Businesses
Table 107. Nordion Radiopharmaceuticals in Nuclear Medical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Nordion Product
Table 109. Nordion Recent Development
Table 110. Ntp Radioisotopes Corporation Information
Table 111. Ntp Radioisotopes Description and Major Businesses
Table 112. Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Ntp Radioisotopes Product
Table 114. Ntp Radioisotopes Recent Development
Table 115. Siemens Healthcare Corporation Information
Table 116. Siemens Healthcare Description and Major Businesses
Table 117. Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. Siemens Healthcare Product
Table 119. Siemens Healthcare Recent Development
Table 120. Taiyo Nippon Sanso Corporation Corporation Information
Table 121. Taiyo Nippon Sanso Corporation Description and Major Businesses
Table 122. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Taiyo Nippon Sanso Corporation Product
Table 124. Taiyo Nippon Sanso Corporation Recent Development
Table 125. Urenco Limited Corporation Information
Table 126. Urenco Limited Description and Major Businesses
Table 127. Urenco Limited Radiopharmaceuticals in Nuclear Medical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Urenco Limited Product
Table 129. Urenco Limited Recent Development
Table 130. Rotem Industries Corporation Information
Table 131. Rotem Industries Description and Major Businesses
Table 132. Rotem Industries Radiopharmaceuticals in Nuclear Medical Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Rotem Industries Product
Table 134. Rotem Industries Recent Development
Table 135. Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Region (2021-2026) (Million US$)
Table 136. Global Radiopharmaceuticals in Nuclear Medical Production Forecast by Regions (2021-2026) (K MT)
Table 137. Global Radiopharmaceuticals in Nuclear Medical Production Forecast by Type (2021-2026) (K MT)
Table 138. Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Type (2021-2026) (Million US$)
Table 139. North America Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Regions (2021-2026) (K MT)
Table 140. Europe Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Regions (2021-2026) (K MT)
Table 141. Asia Pacific Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Regions (2021-2026) (K MT)
Table 142. Latin America Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Regions (2021-2026) (K MT)
Table 143. Middle East and Africa Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Regions (2021-2026) (K MT)
Table 144. Radiopharmaceuticals in Nuclear Medical Distributors List
Table 145. Radiopharmaceuticals in Nuclear Medical Customers List
Table 146. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 147. Key Challenges
Table 148. Market Risks
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Radiopharmaceuticals in Nuclear Medical Product Picture
Figure 2. Global Radiopharmaceuticals in Nuclear Medical Production Market Share by Type in 2020 & 2026
Figure 3. Diagnostic Radiopharmaceuticals Product Picture
Figure 4. Therapy Radiopharmaceuticals Product Picture
Figure 5. Enriched Stable Isotopes Product Picture
Figure 6. Global Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Application in 2020 & 2026
Figure 7. Diagnostic Application
Figure 8. Therapeutic Application
Figure 9. Research
Figure 10. Pharmaceutical
Figure 11. Industrial
Figure 12. Radiopharmaceuticals in Nuclear Medical Report Years Considered
Figure 13. Global Radiopharmaceuticals in Nuclear Medical Revenue 2015-2026 (Million US$)
Figure 14. Global Radiopharmaceuticals in Nuclear Medical Production Capacity 2015-2026 (K MT)
Figure 15. Global Radiopharmaceuticals in Nuclear Medical Production 2015-2026 (K MT)
Figure 16. Global Radiopharmaceuticals in Nuclear Medical Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 17. Radiopharmaceuticals in Nuclear Medical Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Radiopharmaceuticals in Nuclear Medical Production Share by Manufacturers in 2015
Figure 19. The Top 10 and Top 5 Players Market Share by Radiopharmaceuticals in Nuclear Medical Revenue in 2019
Figure 20. Global Radiopharmaceuticals in Nuclear Medical Production Market Share by Region (2015-2020)
Figure 21. Radiopharmaceuticals in Nuclear Medical Production Growth Rate in North America (2015-2020) (K MT)
Figure 22. Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 23. Radiopharmaceuticals in Nuclear Medical Production Growth Rate in Europe (2015-2020) (K MT)
Figure 24. Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 25. Radiopharmaceuticals in Nuclear Medical Production Growth Rate in China (2015-2020) (K MT)
Figure 26. Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 27. Radiopharmaceuticals in Nuclear Medical Production Growth Rate in Japan (2015-2020) (K MT)
Figure 28. Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 29. Global Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Regions 2015-2020
Figure 30. North America Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 31. North America Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Application in 2019
Figure 32. North America Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Countries in 2019
Figure 33. U.S. Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 34. Canada Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 35. Europe Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 36. Europe Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Application in 2019
Figure 37. Europe Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Countries in 2019
Figure 38. Germany Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 39. France Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 40. U.K. Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 41. Italy Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 42. Russia Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 43. Asia Pacific Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (K MT)
Figure 44. Asia Pacific Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Application in 2019
Figure 45. Asia Pacific Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Regions in 2019
Figure 46. China Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 47. Japan Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 48. South Korea Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 49. India Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 50. Australia Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 51. Taiwan Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 52. Indonesia Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 53. Thailand Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 54. Malaysia Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 55. Philippines Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 56. Vietnam Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 57. Latin America Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (K MT)
Figure 58. Latin America Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Application in 2019
Figure 59. Latin America Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Countries in 2019
Figure 60. Mexico Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 61. Brazil Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 62. Argentina Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 63. Middle East and Africa Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (K MT)
Figure 64. Middle East and Africa Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Application in 2019
Figure 65. Middle East and Africa Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Countries in 2019
Figure 66. Turkey Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 67. Saudi Arabia Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 68. U.A.E Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 69. Global Radiopharmaceuticals in Nuclear Medical Production Market Share by Type (2015-2020)
Figure 70. Global Radiopharmaceuticals in Nuclear Medical Production Market Share by Type in 2019
Figure 71. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Type (2015-2020)
Figure 72. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Type in 2019
Figure 73. Global Radiopharmaceuticals in Nuclear Medical Production Market Share Forecast by Type (2021-2026)
Figure 74. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share Forecast by Type (2021-2026)
Figure 75. Global Radiopharmaceuticals in Nuclear Medical Market Share by Price Range (2015-2020)
Figure 76. Global Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Application (2015-2020)
Figure 77. Global Radiopharmaceuticals in Nuclear Medical Value (Consumption) Market Share by Application (2015-2020)
Figure 78. Global Radiopharmaceuticals in Nuclear Medical Consumption Market Share Forecast by Application (2021-2026)
Figure 79. Bracco Imaging Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. Cambridge Isotope Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. Cardinal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Eczacibasi-Monrol Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. Fujifilm Holdings Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. GE Healthcare (Subsidiary Of General Electric Company) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. IBA Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Lantheus Medical Imaging Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Nordion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Ntp Radioisotopes Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Siemens Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Taiyo Nippon Sanso Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Urenco Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Rotem Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 95. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share Forecast by Regions ((2021-2026))
Figure 96. Global Radiopharmaceuticals in Nuclear Medical Production Forecast by Regions (2021-2026) (K MT)
Figure 97. North America Radiopharmaceuticals in Nuclear Medical Production Forecast (2021-2026) (K MT)
Figure 98. North America Radiopharmaceuticals in Nuclear Medical Revenue Forecast (2021-2026) (US$ Million)
Figure 99. Europe Radiopharmaceuticals in Nuclear Medical Production Forecast (2021-2026) (K MT)
Figure 100. Europe Radiopharmaceuticals in Nuclear Medical Revenue Forecast (2021-2026) (US$ Million)
Figure 101. China Radiopharmaceuticals in Nuclear Medical Production Forecast (2021-2026) (K MT)
Figure 102. China Radiopharmaceuticals in Nuclear Medical Revenue Forecast (2021-2026) (US$ Million)
Figure 103. Japan Radiopharmaceuticals in Nuclear Medical Production Forecast (2021-2026) (K MT)
Figure 104. Japan Radiopharmaceuticals in Nuclear Medical Revenue Forecast (2021-2026) (US$ Million)
Figure 105. Global Radiopharmaceuticals in Nuclear Medical Consumption Market Share Forecast by Region (2021-2026)
Figure 106. Radiopharmaceuticals in Nuclear Medical Value Chain
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Porter's Five Forces Analysis
Figure 110. Bottom-up and Top-down Approaches for This Report
Figure 111. Data Triangulation
Figure 112. Key Executives Interviewed
Figure 1. Radiopharmaceuticals in Nuclear Medical Product Picture
Figure 2. Global Radiopharmaceuticals in Nuclear Medical Production Market Share by Type in 2020 & 2026
Figure 3. Diagnostic Radiopharmaceuticals Product Picture
Figure 4. Therapy Radiopharmaceuticals Product Picture
Figure 5. Enriched Stable Isotopes Product Picture
Figure 6. Global Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Application in 2020 & 2026
Figure 7. Diagnostic Application
Figure 8. Therapeutic Application
Figure 9. Research
Figure 10. Pharmaceutical
Figure 11. Industrial
Figure 12. Radiopharmaceuticals in Nuclear Medical Report Years Considered
Figure 13. Global Radiopharmaceuticals in Nuclear Medical Revenue 2015-2026 (Million US$)
Figure 14. Global Radiopharmaceuticals in Nuclear Medical Production Capacity 2015-2026 (K MT)
Figure 15. Global Radiopharmaceuticals in Nuclear Medical Production 2015-2026 (K MT)
Figure 16. Global Radiopharmaceuticals in Nuclear Medical Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 17. Radiopharmaceuticals in Nuclear Medical Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Radiopharmaceuticals in Nuclear Medical Production Share by Manufacturers in 2015
Figure 19. The Top 10 and Top 5 Players Market Share by Radiopharmaceuticals in Nuclear Medical Revenue in 2019
Figure 20. Global Radiopharmaceuticals in Nuclear Medical Production Market Share by Region (2015-2020)
Figure 21. Radiopharmaceuticals in Nuclear Medical Production Growth Rate in North America (2015-2020) (K MT)
Figure 22. Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 23. Radiopharmaceuticals in Nuclear Medical Production Growth Rate in Europe (2015-2020) (K MT)
Figure 24. Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 25. Radiopharmaceuticals in Nuclear Medical Production Growth Rate in China (2015-2020) (K MT)
Figure 26. Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 27. Radiopharmaceuticals in Nuclear Medical Production Growth Rate in Japan (2015-2020) (K MT)
Figure 28. Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 29. Global Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Regions 2015-2020
Figure 30. North America Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 31. North America Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Application in 2019
Figure 32. North America Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Countries in 2019
Figure 33. U.S. Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 34. Canada Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 35. Europe Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 36. Europe Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Application in 2019
Figure 37. Europe Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Countries in 2019
Figure 38. Germany Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 39. France Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 40. U.K. Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 41. Italy Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 42. Russia Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 43. Asia Pacific Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (K MT)
Figure 44. Asia Pacific Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Application in 2019
Figure 45. Asia Pacific Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Regions in 2019
Figure 46. China Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 47. Japan Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 48. South Korea Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 49. India Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 50. Australia Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 51. Taiwan Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 52. Indonesia Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 53. Thailand Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 54. Malaysia Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 55. Philippines Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 56. Vietnam Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 57. Latin America Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (K MT)
Figure 58. Latin America Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Application in 2019
Figure 59. Latin America Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Countries in 2019
Figure 60. Mexico Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 61. Brazil Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 62. Argentina Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 63. Middle East and Africa Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (K MT)
Figure 64. Middle East and Africa Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Application in 2019
Figure 65. Middle East and Africa Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Countries in 2019
Figure 66. Turkey Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 67. Saudi Arabia Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 68. U.A.E Radiopharmaceuticals in Nuclear Medical Consumption and Growth Rate (2015-2020) (K MT)
Figure 69. Global Radiopharmaceuticals in Nuclear Medical Production Market Share by Type (2015-2020)
Figure 70. Global Radiopharmaceuticals in Nuclear Medical Production Market Share by Type in 2019
Figure 71. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Type (2015-2020)
Figure 72. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Type in 2019
Figure 73. Global Radiopharmaceuticals in Nuclear Medical Production Market Share Forecast by Type (2021-2026)
Figure 74. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share Forecast by Type (2021-2026)
Figure 75. Global Radiopharmaceuticals in Nuclear Medical Market Share by Price Range (2015-2020)
Figure 76. Global Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Application (2015-2020)
Figure 77. Global Radiopharmaceuticals in Nuclear Medical Value (Consumption) Market Share by Application (2015-2020)
Figure 78. Global Radiopharmaceuticals in Nuclear Medical Consumption Market Share Forecast by Application (2021-2026)
Figure 79. Bracco Imaging Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. Cambridge Isotope Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. Cardinal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Eczacibasi-Monrol Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. Fujifilm Holdings Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. GE Healthcare (Subsidiary Of General Electric Company) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. IBA Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Lantheus Medical Imaging Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Nordion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Ntp Radioisotopes Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Siemens Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Taiyo Nippon Sanso Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Urenco Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Rotem Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 95. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share Forecast by Regions ((2021-2026))
Figure 96. Global Radiopharmaceuticals in Nuclear Medical Production Forecast by Regions (2021-2026) (K MT)
Figure 97. North America Radiopharmaceuticals in Nuclear Medical Production Forecast (2021-2026) (K MT)
Figure 98. North America Radiopharmaceuticals in Nuclear Medical Revenue Forecast (2021-2026) (US$ Million)
Figure 99. Europe Radiopharmaceuticals in Nuclear Medical Production Forecast (2021-2026) (K MT)
Figure 100. Europe Radiopharmaceuticals in Nuclear Medical Revenue Forecast (2021-2026) (US$ Million)
Figure 101. China Radiopharmaceuticals in Nuclear Medical Production Forecast (2021-2026) (K MT)
Figure 102. China Radiopharmaceuticals in Nuclear Medical Revenue Forecast (2021-2026) (US$ Million)
Figure 103. Japan Radiopharmaceuticals in Nuclear Medical Production Forecast (2021-2026) (K MT)
Figure 104. Japan Radiopharmaceuticals in Nuclear Medical Revenue Forecast (2021-2026) (US$ Million)
Figure 105. Global Radiopharmaceuticals in Nuclear Medical Consumption Market Share Forecast by Region (2021-2026)
Figure 106. Radiopharmaceuticals in Nuclear Medical Value Chain
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Porter's Five Forces Analysis
Figure 110. Bottom-up and Top-down Approaches for This Report
Figure 111. Data Triangulation
Figure 112. Key Executives Interviewed
